GlassScriptPhysician profile
Edward L Hall
NPI 1053390153
$4,080.54
in general payments reported to CMS, 2019-2025
25 companies · $2,088 in 2025
The $2,088 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $25.90 · 2021: $207 · 2022: $394 · 2023: $459 · 2024: $647 · 2025: $2,088.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,680 · Travel and Lodging: $937 · Education: $390 · Gift: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,680.47 |
| Travel and Lodging | $936.97 |
| Education | $389.81 |
| Gift | $187.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,314.10 | 2019-2025 | Da Vinci Surgical System |
| Ethicon US, LLC | $88.78 | 2025 | Surgicel Nu-Knit, Vistaseal, Evarrest |
| Pacira Pharmaceuticals Incorporated | $73.57 | 2021-2025 | Exparel |
| Veran Medical Technologies, INC. | $69.89 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $64.22 | 2023-2024 | Tagrisso |
| Angiodynamics, INC. | $50.00 | 2019 | |
| Olympus America INC. | $41.69 | 2021-2022 | |
| Allergan, INC. | $41.53 | 2019 | |
| Abbvie INC. | $33.02 | 2025 | |
| Portola Pharmaceuticals, LLC | $32.37 | 2019 | |
| Kls-Martin L.P. | $28.78 | 2023 | |
| Baxter Healthcare | $22.92 | 2022 | |
| Hologic Sales and Service, LLC | $22.63 | 2023 | Coolseal Generator |
| Asensus Surgical, INC. | $22.01 | 2019 | |
| Integra Lifesciences Corporation | $21.91 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $17.83 | 2023 | Puraply |
| Myriad Genetic Laboratories, INC. | $17.76 | 2024 | Myrisk |
| Atricure, INC. | $17.72 | 2025 | Synergy Ablation System |
| Heron Therapeutics, INC. | $17.53 | 2025 | Zynrelef |
| Merck Sharp & Dohme LLC | $16.51 | 2024 | Lynparza, Keytruda |
| Davol INC. | $16.12 | 2021 | |
| Shire North American Group INC | $13.80 | 2019 | |
| Covidien LP | $13.17 | 2019 | |
| Lexington Medical, INC. | $11.45 | 2023 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Focal Therapeutics, INC. | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.